← All trials
NCT07072585
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 30, 2026
- Primary completion
- Sep 1, 2035
- Completion date
- Sep 1, 2035
- First posted
- Jul 18, 2025
- Last posted
- Sep 25, 2025
- Enrollment
- 1708
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- National Cancer Institute (NCI)Lead sponsor
- National Cancer Institute (NCI)Official
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.